Evidence map›Paper›PMID 42151993›Full record

ArticleHarm reduction journal2026

A mixed methods examination of organizational approaches to fentanyl test strip distribution and training across multiple states.

Kitty H Gelberg, Megan E Hall, Janet E Childerhose, Mary R Russo, Fernando Montero, Kaleigh Niles, Jill Oliveri, Haley Ramsey Harden, Rachel A Vickers-Smith, Arnie Aldridge and 7 more

Abstract read
In one paragraph

Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kitty H GelbergColumbia University, New York City, USA. KayGConsultingLLC@gmail.com.
Megan E HallRTI International, Research Triangle Park, USA.
Janet E ChilderhoseThe Ohio State University College of Medicine, Columbus, USA.
Mary R RussoColumbia University, New York City, USA.
Fernando MonteroColumbia University, New York City, USA.
Kaleigh NilesThe Ohio State University Comprehensive Cancer Center, Columbus, USA.
Jill OliveriThe Ohio State University Comprehensive Cancer Center, Columbus, USA.
Haley Ramsey HardenUniversity of Kentucky, College of Public Health, Lexington, USA.
Rachel A Vickers-SmithUniversity of Kentucky, College of Public Health, Lexington, USA.
Arnie AldridgeRTI International, Research Triangle Park, USA.
Sarah G StengerClinical and Translational Science Institute, The Ohio State University, Columbus, USA.
Katherine R MarksKentucky Department for Behavioral Health, Lexington, USA.
Louisa GilbertColumbia University, New York City, USA.
Sharon L WalshUniversity of Kentucky, College of Medicine, Lexington, USA.
Nabila El-BasselColumbia University, New York City, USA.
Carter RoeberSubstance Abuse and Mental Health Services Administration, Rockville, USA.
Redonna ChandlerNational Institute on Drug Abuse, Rockville, USA.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)UM1DA049406 · NIDA · UNIVERSITY OF KENTUCKY · PI WALSH, SHARON L. · 2019 to 2022
$81.7M
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York StateUM1DA049415 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI EL-BASSEL, NABILA, GILBERT, LOUISA · 2019 to 2023
$77.3M
Optimizing HEALing in Ohio Communities (OHiO)-Health Equity SupplementUM1DA049417 · NIDA · OHIO STATE UNIVERSITY · PI FREISTHLER, BRIDGET J, WINHUSEN, T JOHN · 2019 to 2023
$66.3M
HEALing Communities Study Health Equity ResearchUM1DA049394 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI GLASGOW, LASHAWN, KNOTT, CHARLES · 2019 to 2023
$40.6M
NIDA NIH HHS UM1 DA049417NIH HHS P30 CA016058NIH HHS UM1DA049394NIH HHS UM1DA049406NIH HHS UM1DA049415NIH HHS UM1DA049417SAMHSA HHS UM1DA049394SAMHSA HHS UM1DA049406SAMHSA HHS UM1DA049415SAMHSA HHS UM1DA049417
6 · The paper itself

Abstract

backgroundFentanyl test strips (FTS) have become a critical harm reduction tool, allowing people who use drugs (PWUD) to detect fentanyl in their drug supply and make informed decisions about their drug use. While FTS distribution is increasingly common, there is limited understanding of distribution strategies used by community organizations, and the education and training provided around FTS use. Given the proliferation of fentanyl in the drug supply, and the diverse motivations of PWUD, research is needed to better understand FTS distribution and training practices. This study examines FTS distribution strategies, training approaches, and the facilitators and barriers faced by harm reduction organizations in Kentucky, Ohio, and New York.

methodsWe conducted a mixed-methods study as part of the Stay Safe Study, using a quantitative survey and qualitative interviews with organizations distributing FTS. Organizations included syringe service programs, mobile outreach units, recovery centers, and public health departments. Survey data were used to describe organizational characteristics and distribution practices, while interview data were coded and analyzed for themes related to distribution practices, training, and facilitators and barriers of FTS distribution.

resultsTwenty-eight organizations completed the organizational survey, and staff from 21 organizations participated in interviews. FTS distribution settings varied widely. Most organizations distributed between 100 and 500 FTS monthly, primarily on an "as needed" basis. Legalization of FTS was identified as a key facilitator, and innovative distribution methods included vending machines and mail distribution. Partnerships within the community expanded the reach and accessibility of FTS. Training approaches for both staff and PWUD varied substantially, and organizations faced barriers related to securing buy-in and the time required for training.

conclusionsThis study highlights organizational practices related to FTS distribution and training. Participants viewed FTS as a gateway to providing broader harm reduction services, fostering trust and engagement with PWUD. To maximize the impact of FTS as an overdose prevention tool, it is important to address persistent barriers through tailored distribution and training strategies, sustainable funding, and scalable implementation models.

Indexed as

Analgesics, OpioidFentanylHarm ReductionHumansKentuckyNew YorkOhioAnalgesics, OpioidFentanylCommunity organizationsDrug checkingFentanyl test stripsPWUD

Identifiers

PMID42151993
PMCPMC13371450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.